{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:33:40Z","timestamp":1785346420432,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5251"],"award-info":[{"award-number":["5251"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118376","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:37:45Z","timestamp":1756946265000},"page":"118376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors"],"prefix":"10.1016","volume":"130","author":[{"given":"Menna-Allah W.","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.E.","family":"Dokla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia","family":"Elgammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabah A.T.","family":"Serya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas A.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Fishovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled A.M.","family":"Abouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118376_bb0005","series-title":"Antimicrobial resistance: Global Report On Surveillance","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.bmc.2025.118376_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105923","article-title":"Emergent crisis of antibiotic resistance: a silent pandemic threat to 21st century","volume":"174","author":"Akram","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2025.118376_bb0015","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2147\/IDR.S177247","article-title":"Health care-associated infections - an overview","volume":"11","author":"Haque","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bmc.2025.118376_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005837","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: An enemy amidst us","volume":"12","author":"Kong","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2025.118376_bb0025","author":"CDC"},{"key":"10.1016\/j.bmc.2025.118376_bb0030","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2025.118376_bb0035","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1126\/science.1055144","article-title":"A proteolytic transmembrane signaling pathway and resistance to \u03b2-lactams in Staphylococci","volume":"291","author":"Zhang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bmc.2025.118376_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1749-6632.1971.tb30664.x","article-title":"Extrachromosomal nature of drug resistance in Staphylococcus aureus","volume":"182","author":"Novick","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bmc.2025.118376_bb0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"Celbenin-resistant staphylococci","author":"Jevons","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.bmc.2025.118376_bb0050","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.44.6.1549-1555.2000","article-title":"A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus","volume":"44","author":"Katayama","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118376_bb0055","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1021\/ja0434376","article-title":"Activation for catalysis of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus by bacterial cell wall","volume":"127","author":"Fuda","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0060","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2025.118376_bb0065","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/jacs.6b12565","article-title":"Conformational dynamics in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, allosteric communication network and enablement of catalysis","volume":"139","author":"Mahasenan","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112312","article-title":"Penicillin binding protein 2a: An overview and a medicinal chemistry perspective","volume":"199","author":"Shalaby","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0075","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.3390\/molecules28207008","article-title":"A review on five and six-membered heterocyclic compounds targeting the penicillin-binding protein 2 (PBP2A) of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"28","author":"Ambade","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118376_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ph18040529","article-title":"Uvarinol and dichamanetin derived from Uvaria chamae as potential dual-site inhibitors against PBP2a in methicillin resistant Staphylococcus aureus: an in silico study","volume":"18","author":"Agbebi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2025.118376_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28104240","article-title":"Novel thiazolylketenyl quinazolinones as potential anti-MRSA agents and allosteric modulator for PBP2a","volume":"28","author":"Dai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118376_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00895-23","article-title":"Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus","volume":"67","author":"Jiao","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118376_bb0095","first-page":"247","article-title":"Ceftaroline: a new cephalosporin with activity against MRSA","volume":"3","author":"Duplessis","year":"2011","journal-title":"Clin Med Rev Ther"},{"key":"10.1016\/j.bmc.2025.118376_bb0100","doi-asserted-by":"crossref","first-page":"32096","DOI":"10.1074\/jbc.M112.355644","article-title":"Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole","volume":"287","author":"Lovering","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0105","first-page":"870","article-title":"Structural basis for the \u03b2 lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus","volume":"9","author":"Lim","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.bmc.2025.118376_bb0110","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1021\/ja5030657","article-title":"Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics","volume":"136","author":"Fishovitz","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0115","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/jacs.5b00056","article-title":"Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one","volume":"137","author":"Bouley","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0120","article-title":"Synergistic inhibition mechanism of quinazolinone and piperacillin on penicillin-binding protein 2a: a promising approach for combating methicillin-resistant Staphylococcus aureus","author":"Jiao","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2025.118376_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02637-18","article-title":"The quinazolinone allosteric inhibitor of PBP 2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus","volume":"63","author":"Janardhanan","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118376_bb0130","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1021\/jm501661f","article-title":"Structure\u2013activity relationship for the oxadiazole class of antibiotics","volume":"58","author":"Spink","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019418","article-title":"New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria","volume":"6","author":"Turk","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118376_bb0140","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2174\/1389557514666140820120518","article-title":"Benzimidazoles: an ideal privileged drug scaffold for the design of multitargeted anti-inflammatory ligands","volume":"14","author":"Kaur","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118376_bb0150","first-page":"1","article-title":"Chapter 1 privileged scaffolds in medicinal chemistry: an introduction","volume":"2016","author":"Barreiro","year":"2015","journal-title":"RSC Drug Discov Ser"},{"key":"10.1016\/j.bmc.2025.118376_bb0155","first-page":"228","article-title":"Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: design, synthesis, and biological evaluation","volume":"3","author":"Shalaby","year":"2019","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"10.1016\/j.bmc.2025.118376_bb0160","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1073\/pnas.54.4.1133","article-title":"Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine","volume":"54","author":"Tipper","year":"1965","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2025.118376_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1574-6976.2008.00105.x","article-title":"The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis","volume":"32","author":"Sauvage","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmc.2025.118376_bb0170","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1592\/phco.2005.25.9.1193","article-title":"Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention","volume":"25","author":"Bridy-Pappas","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bmc.2025.118376_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01366","article-title":"Streptococcus pneumoniae\u2019s virulence and host immunity: aging, diagnostics, and prevention","volume":"9","author":"Brooks","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118376_bb0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections \u2014 United States, MMWR","volume":"68","author":"Kourtis","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bmc.2025.118376_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104183","article-title":"\u03b2,\u03b3-Diaryl \u03b1-methylene-\u03b3-butyrolactones as potent antibacterials against methicillin-resistant Staphylococcus aureus","volume":"104","author":"Hamann","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111593","article-title":"Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity","volume":"182","author":"Elsebaei","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0195","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1021\/acs.jmedchem.9b01198","article-title":"Chemical space exploration around thieno[3,2-d]pyrimidin-4(3 H)-one scaffold led to a novel class of highly active Clostridium difficile inhibitors","volume":"62","author":"Shao","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0200","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bmc.2025.118376_bb0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1039\/C9MD00391F","article-title":"Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria","volume":"11","author":"Naclerio","year":"2020","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0210","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsinfecdis.9b00022","article-title":"Inhibitors of intracellular Gram-positive bacterial growth synthesized via Povarov-Doebner reactions","volume":"5","author":"Dayal","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2025.118376_bb0215","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1021\/jacs.5b01374","article-title":"The Tipper-Strominger hypothesis and triggering of allostery in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"137","author":"Fishovitz","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0220","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0225","first-page":"4391","article-title":"Thermal cyclization of o-aroyloxyacetoarones. Part III. Synthesis in the chromone series","author":"O\u2019Toole","year":"1956","journal-title":"J Chem Soc"},{"key":"10.1016\/j.bmc.2025.118376_bb0230","doi-asserted-by":"crossref","DOI":"10.1107\/S1600536812040536","article-title":"2-Acetyl-phenyl (2E)-3-(4-fluoro-phen-yl)acrylate","volume":"68","author":"Momin","year":"2012","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"10.1016\/j.bmc.2025.118376_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17518250903002343","article-title":"Solid Phase Baker\u2013Venkataraman rearrangement under solvent-free condition using grinding technique","volume":"2","author":"Sharma","year":"2009","journal-title":"Green Chem Lett Rev"},{"key":"10.1016\/j.bmc.2025.118376_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/436758","article-title":"Synthesis and evaluation of novel fluorinated 2-styrylchromones as antibacterial agents","volume":"2013","author":"Momin","year":"2013","journal-title":"J Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0245","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1080\/00397918908052583","article-title":"A convenient synthesis of 2-styrylchromones by modified Baker-Venkataraman transformation using phase transfer catalysis","volume":"19","author":"Makrandi","year":"1989","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmc.2025.118376_bb0250","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/ejoc.200900026","article-title":"Efficient syntheses of new polyhydroxylated 2,3-diaryl-9H-xanthen-9-ones","author":"Santos","year":"2009","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0255","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Ninth Edition","volume":"32","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.bmc.2025.118376_bb0260","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bmc.2025.118376_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2019.04.063","article-title":"Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity","volume":"175","author":"Elsebaei","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0270","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1039\/C8RA10525A","article-title":"tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity","volume":"9","author":"Kotb","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118376_bb0275","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure\u2013activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae","author":"Hewitt","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2025.118376_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052427","article-title":"N-(1,3,4-oxadiazol-2-yl)benzamides as antibacterial agents against Neisseria gonorrhoeae","volume":"22","author":"Naclerio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2025.118376_bb0285","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1021\/acs.jmedchem.0c01198","article-title":"Ultrapotent inhibitor of Clostridioides difficile growth, which suppresses recurrence in vivo","volume":"63","author":"Naclerio","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118376_bb0290","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/acsinfecdis.0c00137","article-title":"Development of biphenylthiazoles exhibiting improved pharmacokinetics and potent activity against intracellular Staphylococcus aureus","volume":"6","author":"Hagras","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2025.118376_bb0295","article-title":"Antibacterial evaluation of synthetic thiazole compounds in vitro and in vivo in a methicillin-resistant Staphylococcus aureus (MRSA) skin infection mouse model","volume":"10","author":"Mohammad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118376_bb0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0006-2952(95)02230-9","article-title":"A checkerboard method to evaluate interactions between drugs","volume":"51","author":"Martinez-Irujo","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2025.118376_bb0305","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11059","article-title":"In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci","volume":"9","author":"Abutaleb","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.bmc.2025.118376_bb0310","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ijantimicag.2018.08.016","article-title":"Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris","volume":"52","author":"Eldesouky","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2025.118376_bb0315","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","article-title":"Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2025.118376_bb0320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00280-015-2924-3","article-title":"In vitro characterization of transport and metabolism of the alkaloids: vincamine, vinpocetine and eburnamonine","volume":"77","author":"Fandy","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bmc.2025.118376_bb0325","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/jpet.109.165084","article-title":"Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse","volume":"333","author":"Mason","year":"2010","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:57:47Z","timestamp":1762347467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":65,"alternative-id":["S0968089625003177"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118376","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118376"}}